DICE Therapeutics Inc (DICE)
US23345J1043 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -90.94M | -83.89M | -48.96M | -23.74M | -12.94M | |||
| Depreciation Amortization | 918.00K | 825.00K | 661.00K | 697.00K | 706.00K | |||
| Change In Working Capital | 962.00K | 2.64M | 1.65M | 1.66M | -4.65M | |||
| Interest Paid | N/A | 76.00K | 81.00K | N/A | N/A | |||
| Other non cash items | 16.47M | 16.10M | 7.36M | 700.00K | 583.00K | |||
| OPERATING CASH FLOW | -72.59M | -64.32M | -39.29M | -20.68M | -16.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.05M | -2.24M | -718.00K | -148.00K | -981.00K | |||
| Other Investing Activity | -200.23M | 89.72M | -203.91M | 18.15M | -18.15M | |||
| INVESTING CASH FLOW | -202.28M | 87.49M | -204.62M | 18.00M | -19.13M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -2.64M | 2.32M | -122.00K | -278.00K | |||
| Stock Issued/Repurchased | 325.39M | 325.12M | 297.98M | 54.35M | 0.00 | |||
| Other Financing Activity | -93.00K | -226.00K | -45.00K | -331.00K | 0.00 | |||
| FINANCING CASH FLOW | 322.65M | 322.25M | 300.25M | 53.90M | -278.00K | |||
| CHANGE IN CASH | 47.78M | 345.42M | 56.34M | 51.22M | -35.71M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -72.59M | -64.32M | -39.29M | -20.68M | -16.30M | |||
| Capital Expenditure | -2.05M | -2.24M | -718.00K | -148.00K | -981.00K | |||
| FREE CASH FLOW | -74.65M | -66.56M | -40.01M | -20.83M | -17.28M | |||
All data in USD